ESMO Receives ‘Special Consultative Status’ with the UN Economic and Social Council (ECOSOC)
ESMO has been granted ‘special consultation status’ with the United Nations Economic and Social Council (ECOSOC).
ESMO Policy News
EMA 25th Anniversary Symposium: New Approaches In Patient-Focused Cancer Drug Development
ESMO President Solange Peters and ESMO officers Paolo G. Casali and Elisabeth De Vries have been invited to speak at the virtual meeting [29 October] marking 25 years of EMA's strong commitment to protect public health with a focus on cancer
ESMO Congratulates the United Nations on 75 Years of Achievements in Defence of Health as a Human Right
ESMO congratulated the United Nations on 75 years of achievements in defence of health as a human right which it celebrated in a virtual High-Level Meeting to Commemorate the 75th Anniversary of the United Nations on 21 September.
ESMO supports WHO Europe’s European Programme of Work 2020-2025
An ambitious European Programme of Work (EPW 2020–2025) – “United Action for Better Health in Europe” has just been adopted by WHO Europe at its virtual Regional Committee Meeting (14-15 September 2020)
ESMO Supports WHO Resolution on ‘COVID-19 Response’ and Launches Resources to Minimise Risks to Cancer Patients
The World Health Organization Releases Guide to Update National Essential Medicines Lists
WHO Guide ‘Selection of Essential Medicines at Country Level: Using the WHO Model List of Essential Medicines to update a national essential medicines list’
Biosimilars have a fascinating story of development and understanding it is crucial for widespread adoption
Biosimilars have a fascinating story of development, says Rosa Giuliani, and understanding it is crucial for widespread adoption.
ESMO and ASCO call on governments to improve cancer services and reduce cancer deaths
The European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO), the world’s two leading organisations for oncology professionals, today issued a joint statement calling upon governments to renew political commitment to improve cancer services and reduce cancer deaths.